DOI: 10.26717/BJSTR.2017.01.000109
*Corresponding author:
V Balaram, CSIR, National Geophysical Research Institute, Hyderabad – 500 007, IndiaReceived: April 12, 2017 Published: May 25, 2017
To view the Full Article Peer-reviewed Article PDF
EP: European Pharmacopoeia; USP: United States Pharmacopoeia; ICH: International Conference on Harmonization; EMA: European Medicines Agency; FDA: Food and Drug Administration; BP: British Pharmacopeia; JP: Japanese Pharmacopoeia; IP: Indian Pharmacopoeia; PDE: Permitted Daily Exposure
Mini Review | Conclusion | Figures | References |